Vivek Thappa MD in Belvidere, Illinois

Home Illinois Belvidere

Vivek Thappa MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 1700 Henry Luckow Ln in Belvidere, Illinois. There are 9 additional office locations for Vivek Thappa MD that can be viewed towards the end of their profile.

They're a part of the: Swedishamerican Hospital medical group which has around 273 members. You can call their office at 779-696-8650 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1977 (around 47 years of experience). They are listed as doing telehealth appointments.

Vivek Thappa MD Office Phone and Directions

Vivek Thappa MD
Swedishamerican Hospital
1700 Henry Luckow Ln
Belvidere, Illinois 61008
779-696-8650

Patient Ratings
Please rate your experience with Vivek Thappa MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 779-696-8650

Enter a starting address:

Healthcare Info for Vivek Thappa MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1977
The Primary Medical Specialty for Vivek Thappa MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 47
PAC (PECOS ID)#: 2860441813
NPI #: 1295743383
NPI Created On: 08/04/2006
NPI Last Updated Listed as: 02/19/2021
Primary Taxonomy Code: 207RS0012X
License Number:
036081657
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Sleep monitoring of patient (6 years or older) in sleep lab
Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 30 minutes per day
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Physician telephone patient service, 5-10 minutes of medical discussion
Physician telephone patient service, 11-20 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801708501

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802739351

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802965711

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768823778

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768823780

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest

Payments Total: $98

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843463485

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809630911

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809630913

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809630915

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763682472

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: STIOLTO RESPIMAT

Open Associated Drug #1: 0597-0155-61

Drug or Biological: Drug

Product Category #2: RESPIRATORY

Name Of Drug #2:: SPIRIVA RESPIMAT

Associated Drug #2: 0597-0100-61